Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes
Authors:
- Moshe NussinovitchMNMoshe Nussinovitch
- Itzhak VarsanoIVItzhak Varsano
- 1 April 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 101 (4) , 464-469
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind studyJournal of Allergy and Clinical Immunology, 1996
- Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers*Acta Paediatrica, 1996
- Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.Archives of Disease in Childhood, 1993
- How much nebulised budesonide reaches infants and toddlers?Archives of Disease in Childhood, 1992
- Aerosol Steroids as Primary Treatment of Mild AsthmaNew England Journal of Medicine, 1991
- Inhaled budesonide for treatment of recurrent wheezing in early childhoodThe Lancet, 1990
- Aerosolized budesonide in asthmatic infants: A double blind studyPediatric Pulmonology, 1990
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Bioequivalent doses of budesonide and prednisone in moderate and severe asthmaJournal of Allergy and Clinical Immunology, 1989
- Nebulised beclomethasone dipropionate suspension.Archives of Disease in Childhood, 1986